[Application of cluster randomization method on typhoid Vi vaccine trails]

Area of Science:

• Epidemiology
• Clinical Trials
• Vaccinology

Context:

• Typhoid Vi vaccine efficacy trials require robust methodologies to minimize bias.
• Cluster randomization offers a strategy for evaluating interventions in populations where individual randomization is impractical.
• Assessing the feasibility and effectiveness of cluster randomization is crucial for public health interventions.

Purpose:

• To detail the design and application of the cluster randomized controlled method in a typhoid Vi vaccine trial.
• To evaluate the impact of implementing cluster randomization on controlling confounding variables.
• To assess the practical implementation and acceptance of this trial design.

Summary:

• A cluster randomized controlled trial was designed to evaluate the typhoid Vi vaccine, with participants assigned to receive either the typhoid Vi vaccine or a meningococcal A vaccine.
• Sample size calculations guided the recruitment of 96,121 participants across 108 clusters, with 53 study clusters (44,054 participants) and 54 control clusters (48,422 participants) ultimately randomized after stratification and matching.
• Analysis revealed comparable and balanced confounding factors (age, sex, location, income, education) between the two groups, indicating successful control of biases.

Impact:

• Cluster randomization enhances the scientific rigor of vaccine trials by effectively controlling confounding factors.
• The implementation of cluster randomization in vaccine trials is practical, simple, and readily accepted.
• This methodology facilitates more reliable evaluation of vaccine interventions and informs future trial designs.